Andrei Stoica
Chief Tech/Sci/R&D Officer chez BUTTERFLY NETWORK, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Andrei Stoica is currently the Chief Technology Officer at Butterfly Network, Inc. He previously worked as the Chief Technology Officer at BioTelemetry, Inc. and as the Vice President-Systems Development at IQVIA Holdings, Inc. He holds a doctorate degree from the University of South Carolina.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
02/04/2024 | 1 497 558 ( 0,82% ) | 2 M $ | 31/03/2024 |
Postes actifs de Andrei Stoica
Sociétés | Poste | Début |
---|---|---|
BUTTERFLY NETWORK, INC. | Chief Tech/Sci/R&D Officer | 19/07/2021 |
Anciens postes connus de Andrei Stoica
Sociétés | Poste | Fin |
---|---|---|
BIOTELEMETRY, INC. | Chief Tech/Sci/R&D Officer | - |
IQVIA HOLDINGS INC. | Corporate Officer/Principal | - |
Formation de Andrei Stoica
University of South Carolina | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
IQVIA HOLDINGS INC. | Health Services |
BUTTERFLY NETWORK, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
BioTelemetry, Inc.
BioTelemetry, Inc. Medical SpecialtiesHealth Technology BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through the following segments: Healthcare, and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA. | Health Technology |